| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 31 |
| 1 | ASPIRIN 325 MG | 30 |
| 2 | ASPIRIN 81 MG | 30 |
| 3 | FUROSEMIDE | 30 |
| 4 | CYTARABINE | 27 |
| 5 | LORAZEPAM | 22 |
| 6 | CYCLOPHOSPHAMIDE | 21 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 9 | METHOTREXATE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NYSTATIN TOPICAL POWDER | 1 | 0.0312 |
| 1 | FIRST AID ANTIBIOTIC | 1 | 0.0042 |
| 2 | SETMELANOTIDE | 1 | 0.0035 |
| 3 | PORFIMER SODIUM | 1 | 0.0029 |
| 4 | CALCIUM ANTACID | 1 | 0.0023 |
| 5 | IBUPROFEN LYSINE | 1 | 0.0018 |
| 6 | PENTAMIDINE ISETHIONATE | 2 | 0.0016 |
| 7 | ACYCLOVIR SODIUM | 2 | 0.0016 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 13 | 0.0016 |
| 9 | CEFOXITIN SODIUM | 2 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 57 |
| 1 | Corticosteroid [EPC] | 47 |
| 2 | Benzodiazepine [EPC] | 40 |
| 3 | Alkylating Drug [EPC] | 34 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 33 |
| 5 | Loop Diuretic [EPC] | 32 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 31 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| 8 | Platinum-based Drug [EPC] | 22 |
| 9 | Opioid Agonist [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 3 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 4 | Actinomycin [EPC] | 1 | 0.0005 |
| 5 | Benzothiazole [EPC] | 1 | 0.0004 |
| 6 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 7 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 8 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |